Chemoinformaics analysis of (E)-Opposita-4(15),7(11)-dien-12-ol
| Molecular Weight | 220.356 | nRot | 2 |
| Heavy Atom Molecular Weight | 196.164 | nRig | 12 |
| Exact Molecular Weight | 220.183 | nRing | 2 |
| Solubility: LogS | -2.963 | nHRing | 0 |
| Solubility: LogP | 3.443 | No. of Aliphatic Rings | 2 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 2 |
| Atoms Count | 40 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 16 | No. of Aromatic Carbocycles | 0 |
| nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 2 |
| No. of Hydrogen atom | 24 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 15 | No. of Saturated Rings | 2 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
| nHA | 1 | APOL | 41.855 |
| nHD | 1 | BPOL | 24.077 |
| QED | 0.704 |
| Synth | 4.377 |
| Natural Product Likeliness | 2.907 |
| NR-PPAR-gamma | 0.003 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.006 |
| Pgp-sub | 0 |
| HIA | 0.004 |
| CACO-2 | -4.437 |
| MDCK | 0.0000138 |
| BBB | 0.92 |
| PPB | 0.797492 |
| VDSS | 1.586 |
| FU | 0.158714 |
| CYP1A2-inh | 0.275 |
| CYP1A2-sub | 0.622 |
| CYP2c19-inh | 0.132 |
| CYP2c19-sub | 0.821 |
| CYP2c9-inh | 0.118 |
| CYP2c9-sub | 0.12 |
| CYP2d6-inh | 0.037 |
| CYP2d6-sub | 0.651 |
| CYP3a4-inh | 0.487 |
| CYP3a4-sub | 0.309 |
| CL | 8.438 |
| T12 | 0.156 |
| hERG | 0.009 |
| Ames | 0.051 |
| ROA | 0.228 |
| SkinSen | 0.116 |
| Carcinogencity | 0.354 |
| EI | 0.689 |
| Respiratory | 0.5 |
| NR-Aromatase | 0.05 |
| Antiviral | Yes |
| Prediction | 0.890931 |